The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 24, 2024

Filed:

Jun. 28, 2022
Applicant:

Avrio Genetics Llc, Allentown, PA (US);

Inventors:

James Strader, Austin, TX (US);

Jovan Hutton Pulitzer, Frisco, TX (US);

Assignee:

Avrio Genetics LLC, Allentown, PA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/70 (2006.01); A61K 9/06 (2006.01); A61K 31/4188 (2006.01); A61K 31/437 (2006.01); A61K 39/00 (2006.01); A61K 39/35 (2006.01); A61K 39/36 (2006.01); A61K 45/06 (2006.01); A61P 17/00 (2006.01); A61P 37/02 (2006.01); A61P 37/08 (2006.01); A61K 47/10 (2017.01); A61K 47/12 (2006.01);
U.S. Cl.
CPC ...
A61K 9/7092 (2013.01); A61K 9/06 (2013.01); A61K 9/7084 (2013.01); A61K 31/4188 (2013.01); A61K 31/437 (2013.01); A61K 39/0008 (2013.01); A61K 39/35 (2013.01); A61K 39/36 (2013.01); A61K 45/06 (2013.01); A61P 17/00 (2018.01); A61P 37/02 (2018.01); A61P 37/08 (2018.01); A61K 9/703 (2013.01); A61K 2039/54 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01);
Abstract

A method for creating a consolidated compound for delivering an immunomodulatory and imiquimod to a patient, comprising diluting immunomodulator extract to a desired dilution by transferring a desired quantity of the concentrated immunomodulator to an associated sterile container, the associated sterile container having a defined volume of diluted immunomodulator after dilution thereof, providing a viscous encapsulation material, selecting a prescribed amount of concentrated immunomodulator, the prescribed amount defined as that amount of the diluted immunomodulator extract required to provide a number of doses equal to the number of dispensable increments from the container containing the viscous encapsulation material, introducing the selected amount of each of the diluted immunomodulator extract into the viscous encapsulation material, introducing an amount of imiquimod into the viscous encapsulation material, and mixing the introduced amount of each of the diluted immunomodulator extracts and the introduced amount of imiquimod with the viscous encapsulating material.


Find Patent Forward Citations

Loading…